Phosphorylation-Dependent Structural Changes in the N-Terminal Extension of SUR2A NBD1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Iron Depletion Reduces Abce1 Transcripts While Inducing The
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 22 October 2019 doi:10.20944/preprints201910.0252.v1 1 Research Article 2 Iron depletion Reduces Abce1 Transcripts While 3 Inducing the Mitophagy Factors Pink1 and Parkin 4 Jana Key 1,2, Nesli Ece Sen 1, Aleksandar Arsovic 1, Stella Krämer 1, Robert Hülse 1, Suzana 5 Gispert-Sanchez 1 and Georg Auburger 1,* 6 1 Experimental Neurology, Goethe University Medical School, 60590 Frankfurt am Main; 7 2 Faculty of Biosciences, Goethe-University Frankfurt am Main, Germany 8 * Correspondence: [email protected] 9 10 Abstract: Lifespan extension was recently achieved in Caenorhabditis elegans nematodes by 11 mitochondrial stress and mitophagy, triggered via iron depletion. Conversely in man, deficient 12 mitophagy due to Pink1/Parkin mutations triggers iron accumulation in patient brain and limits 13 survival. We now aimed to identify murine fibroblast factors, which adapt their mRNA expression 14 to acute iron manipulation, relate to mitochondrial dysfunction and may influence survival. After 15 iron depletion, expression of the plasma membrane receptor Tfrc with its activator Ireb2, the 16 mitochondrial membrane transporter Abcb10, the heme-release factor Pgrmc1, the heme- 17 degradation enzyme Hmox1, the heme-binding cholesterol metabolizer Cyp46a1, as well as the 18 mitophagy regulators Pink1 and Parkin showed a negative correlation to iron levels. After iron 19 overload, these factors did not change expression. Conversely, a positive correlation of mRNA levels 20 with both conditions of iron availability was observed for the endosomal factors Slc11a2 and Steap2, 21 as well as for the iron-sulfur-cluster (ISC)-containing factors Ppat, Bdh2 and Nthl1. -
Effects of Silencing the ATP-Binding Cassette Protein E1 Gene by Electroporation on the Proliferation and Migration of EC109 Human Esophageal Cancer Cells
MOLECULAR MEDICINE REPORTS 12: 837-842, 2015 Effects of silencing the ATP-binding cassette protein E1 gene by electroporation on the proliferation and migration of EC109 human esophageal cancer cells XIAO-RUI LI, LIU-ZHONG YANG, XIAO-QING HUO, YING WANG, QING-HUI YANG and QING-QIN ZHANG Department of Oncology, The First Affiliated Hospital of Xinxiang Medical College, Weihui, Henan 453100, P.R. China Received February 17, 2014; Accepted November 19, 2014 DOI: 10.3892/mmr.2015.3512 Abstract. In the present study, the gene expression of invasion and migration in esophageal cancer and silencing the ATP-binding cassette protein E1 (ABCE1) in the EC109 ABCE1 gene by electroporation can significantly reduce the human esophageal cancer cell line was silenced using elec- proliferation, invasion and migration capacity of EC109 cells troporation to examine the effect if the ABCE1 gene on the in vitro. growth migration and cell cycle of cancer cells. The small interference (si)RNA sequence of ABCE1 was designed and Introduction synthesized to transfect the EC109 cells by electroporation. The mRNA and protein expression levels of ABCE1 were Esophageal cancer is one of most common types of gastro- then detected by reverse transcription quantitative polymerase intestinal malignant tumor in humans. The incidence of the chain reaction (RT-qPCR) and western blot analysis. The disease is higher in developing countries and the majority of analysis of the cell cycle and apoptosis was performed using tumors are squamous carcinoma (1). Although chemotherapy flow cytometry. The effect of silencing the ABCE1 gene on and adjuvant chemotherapy are widely used the treatment of the proliferation, migration and invasive ability of the EC109 esophageal cancer, the prognosis remains poor, particularly human esophageal cancer cells were assessed using a Cell in patients with clinical migration and tumor recurrence (2,3). -
Sulfonylurea Stimulation of Insulin Secretion Peter Proks,1 Frank Reimann,2 Nick Green,1 Fiona Gribble,2 and Frances Ashcroft1
Sulfonylurea Stimulation of Insulin Secretion Peter Proks,1 Frank Reimann,2 Nick Green,1 Fiona Gribble,2 and Frances Ashcroft1 Sulfonylureas are widely used to treat type 2 diabetes smooth, and skeletal muscle, and some brain neurones. In because they stimulate insulin secretion from pancre- all these tissues, opening of KATP channels in response to atic -cells. They primarily act by binding to the SUR metabolic stress leads to inhibition of electrical activity. subunit of the ATP-sensitive potassium (KATP) channel Thus they are involved in the response to both cardiac and and inducing channel closure. However, the channel is cerebral ischemia (2). They are also important in neuronal still able to open to a limited extent when the drug is regulation of glucose homeostasis (3), seizure protection bound, so that high-affinity sulfonylurea inhibition is not complete, even at saturating drug concentrations. (4), and the control of vascular smooth muscle tone (and, thereby, blood pressure) (5). KATP channels are also found in cardiac, skeletal, and smooth muscle, but in these tissues are composed of The KATP channel is a hetero-octameric complex of two different SUR subunits that confer different drug different types of protein subunits: an inwardly rectifying sensitivities. Thus tolbutamide and gliclazide block Kϩ channel, Kir6.x, and a sulfonylurea receptor, SUR (6,7).  ϩ channels containing SUR1 ( -cell type), but not SUR2 Kir6.x belongs to the family of inwardly rectifying K (cardiac, smooth muscle types), whereas glibenclamide, (Kir) channels and assembles as a tetramer to form the glimepiride, repaglinide, and meglitinide block both types of channels. -
ABCG2, ABCC2, ABCC1, ABCC3 and Multiple Myeloma Risk: a Case--Control Study in the Context of the International Multiple Myeloma Research (Immense) Consortium
Letters to the Editor 1419 Program, The Japanese Cord Blood Bank Network and The Japanese Society of myeloid leukemia or myelodysplastic syndrome who have chromosome 5 Pediatric Hematology. We also thank Ms Takako Sakai, data manager of the Japan and/or 7 abnormalities. Haematologica 2005; 90: 1339 -- 1345. Society for Hematopoietic Cell Transplantation Data Registry, for their excellent 2 Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A assistance. et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern K Ishiyama1,2, A Takami1,13, Y Kanda3,13, S Nakao1, M Hidaka4, Cooperative Oncology Group Study. Blood 2000; 96: 4075 -- 4083. T Maeda5, T Naoe6, S Taniguchi7, K Kawa8, T Nagamura9, 3 Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Kanamori H, Usuki K et al. K Tabuchi10, Y Atsuta11 and H Sakamaki12 A Markov decision analysis of allogeneic hematopoietic cell transplantation 1Department of Cellular Transplantation Biology, versus chemotherapy in patients with acute myeloid leukemia in first remission. Kanazawa University Graduate School of Medical Sciences, Blood 2011; 117: 2113 -- 2120. 4 Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA Kanazawa, Ishikawa, Japan; 2 et al. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes Department of Hematology, Tokyo Metropolitan the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid Ohtsuka Hospital, Toshima, Tokyo, Japan; malignancies. Leukemia 2006; 20: 1295 -- 1297. 3 Division of Hematology, Saitama Medical Center, 5 Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T et al. -
A Small Interfering ABCE1 -Targeting RNA Inhibits the Proliferation And
687-693.qxd 23/3/2010 01:55 ÌÌ Page 687 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 25: 687-693, 2010 687 A small interfering ABCE1-targeting RNA inhibits the proliferation and invasiveness of small cell lung cancer BO HUANG, YING GAO, DALI TIAN and MAOGEN ZHENG Department of Thoracic Surgery, the Fourth Affiliated Hospital of China Medical University, Liaoning Shenyan 110032, P.R. China Received November 13, 2009; Accepted December 22, 2009 DOI: 10.3892/ijmm_00000392 Abstract. Small cell lung cancer (SCLC) is a highly aggres- cases. SCLC is generally unsuitable for surgical resection. sive lung neoplasm. To study the pathogenesis of SCLC, we Although radiotherapy and chemotherapy have produced investigated roles of ABCE1, a member of the ATP-binding modest benefits for some patients, it could lead to recurrent cassette (ABC) superfamily, in the development of small cell and multidrug resistance (4). Recently gene therapy, as one lung cancer. RNA interference was used to knock down prevalent strategy, has being considered and employed in ABCE1 expression in human small cell lung cancer cell lines practice. Several genes have been explored for treating cancer, (NCI-H446). Then we examined the effects of ABCE1 knock- including tumor necrosis factor, p53, tumor suppressor gene, down in cancer cells, including proliferation, invasiveness, Herpes Simplex Virus Type-1 (HSV-1) and bacterial cytosine apoptosis, and gene expression. We found that ABCE1 could deaminase (CD) gene. However, clinical trials have shown be efficiently knocked down by siRNA, and the ABCE1 that the therapeutic outcome was severely restricted by the silence inhibited the proliferation, invasiveness of small cell poor efficiency of current gene transfer vector systems. -
Rnase L) (OAS) [(Baglioni Et Al
R Ribonuclease L (RNase L) (OAS) [(Baglioni et al. 1978), reviewed by (Hovanessian and Justesen 2007)]. Melissa Drappier and Thomas Michiels Based on these observations, an RNase de Duve Institute, Université catholique de L activation model was proposed (Fig. 2). In this Louvain, Brussels, Belgium model, virus infection induces IFN expression, which, in turn, triggers the upregulation of OAS expression. dsRNA synthesized in the course of Synonyms viral infection binds OAS, leading to the activa- tion of OAS catalytic activity and to the synthesis PRCA1; RNS4 of 2-5A molecules. 2-5A in turn bind to RNase L, which is present in cells as a latent enzyme. Upon 2-5A binding, RNase L becomes activated by dimerization and cleaves viral and cellular RNA Historical Background (Fig. 2). Since then, cloning of the RNase L gene in In early stages of viral infection, the innate 1993 (Zhou et al. 1993), generation of RNase immune response and particularly the interferon À À L-deficient (RNase L / ) mice in 1997 (Zhou response play a critical role in restricting viral et al. 1997), and solving RNase L structure (Han replication and propagation, awaiting the estab- et al. 2014; Huang et al. 2014) were the major lishment of the adaptive immune response. One of milestones in the understanding of RNase the best-described IFN-dependent antiviral L function. responses is the OAS/RNase L pathway. This two-component system is controlled by type I and type III interferons (IFN). Back in the General Features, Biochemistry, 1970s, the groups of I. Kerr and P. Lengyel dis- and Regulation of RNase L Activity covered a cellular endoribonuclease (RNase) activity that was increased by IFN and depended RNase L is the effector enzyme of the on the presence of double-stranded RNA IFN-induced, OAS/RNase L pathway. -
The Genetic Basis of Congenital Hyperinsulinism Chela James, Ritika K Kapoor, Dunia Ismail, Khalid Hussain
The genetic basis of congenital hyperinsulinism Chela James, Ritika K Kapoor, Dunia Ismail, Khalid Hussain To cite this version: Chela James, Ritika K Kapoor, Dunia Ismail, Khalid Hussain. The genetic basis of congeni- tal hyperinsulinism. Journal of Medical Genetics, BMJ Publishing Group, 2009, 46 (5), pp.289. 10.1136/jmg.2008.064337. hal-00552677 HAL Id: hal-00552677 https://hal.archives-ouvertes.fr/hal-00552677 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. The genetic basis of congenital hyperinsulinism Chela James, Ritika R Kapoor, Dunia Ismail, Khalid Hussain London Centre for Paediatric Endocrinology and Metabolism, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, and The Institute of Child Health, University College London WC1N 1EH UK. Correspondence to Dr. K. Hussain Developmental Endocrinology Research Group Clinical and Molecular Genetics Unit Institute of Child Health University College London 30 Guilford Street, London WC1N 1EH. Tele: ++44 (0)20 7 905 2128 Fax: ++44 (0)20 7 404 6191 Email [email protected] The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in Journal of Medical Genetics and any other BMJPGL products to exploit all subsidiary rights, as set out in our licence (http://jmg.bmj.com/iforalicence.pdf). -
Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice. -
ABC Transporter Subfamily D: Distinct Differences in Behavior Between ABCD1–3 and ABCD4 in Subcellular Localization, Function, and Human Disease
Hindawi Publishing Corporation BioMed Research International Volume 2016, Article ID 6786245, 11 pages http://dx.doi.org/10.1155/2016/6786245 Review Article ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1–3 and ABCD4 in Subcellular Localization, Function, and Human Disease Kosuke Kawaguchi and Masashi Morita Department of Biological Chemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan Correspondence should be addressed to Kosuke Kawaguchi; [email protected] Received 24 June 2016; Accepted 29 August 2016 Academic Editor: Hiroshi Nakagawa Copyright © 2016 K. Kawaguchi and M. Morita. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ATP-binding cassette (ABC) transporters are one of the largest families of membrane-bound proteins and transport a wide variety of substrates across both extra- and intracellular membranes. They play a critical role in maintaining cellular homeostasis. To date, four ABC transporters belonging to subfamily D have been identified. ABCD1–3 and ABCD4 are localized to peroxisomes and lysosomes, respectively. ABCD1 and ABCD2 are involved in the transport of long and very long chain fatty acids (VLCFA) or their CoA-derivatives into peroxisomes with different substrate specificities, while ABCD3 is involved in the transport of branched chain acyl-CoA into peroxisomes. On the other hand, ABCD4 is deduced to take part in the transport of vitamin B12 from lysosomes into the cytosol. It is well known that the dysfunction of ABCD1 results in X-linked adrenoleukodystrophy, a severe neurodegenerative disease. -
Whole-Exome Sequencing Identifies Novel Mutations in ABC Transporter
Liu et al. BMC Pregnancy and Childbirth (2021) 21:110 https://doi.org/10.1186/s12884-021-03595-x RESEARCH ARTICLE Open Access Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study Xianxian Liu1,2†, Hua Lai1,3†, Siming Xin1,3, Zengming Li1, Xiaoming Zeng1,3, Liju Nie1,3, Zhengyi Liang1,3, Meiling Wu1,3, Jiusheng Zheng1,3* and Yang Zou1,2* Abstract Background: Intrahepatic cholestasis of pregnancy (ICP) can cause premature delivery and stillbirth. Previous studies have reported that mutations in ABC transporter genes strongly influence the transport of bile salts. However, to date, their effects are still largely elusive. Methods: A whole-exome sequencing (WES) approach was used to detect novel variants. Rare novel exonic variants (minor allele frequencies: MAF < 1%) were analyzed. Three web-available tools, namely, SIFT, Mutation Taster and FATHMM, were used to predict protein damage. Protein structure modeling and comparisons between reference and modified protein structures were performed by SWISS-MODEL and Chimera 1.14rc, respectively. Results: We detected a total of 2953 mutations in 44 ABC family transporter genes. When the MAF of loci was controlled in all databases at less than 0.01, 320 mutations were reserved for further analysis. Among these mutations, 42 were novel. We classified these loci into four groups (the damaging, probably damaging, possibly damaging, and neutral groups) according to the prediction results, of which 7 novel possible pathogenic mutations were identified that were located in known functional genes, including ABCB4 (Trp708Ter, Gly527Glu and Lys386Glu), ABCB11 (Gln1194Ter, Gln605Pro and Leu589Met) and ABCC2 (Ser1342Tyr), in the damaging group. -
ABCA7 and Pathogenic Pathways of Alzheimer's Disease
brain sciences Review ABCA7 and Pathogenic Pathways of Alzheimer’s Disease Tomonori Aikawa, Marie-Louise Holm ID and Takahisa Kanekiyo * Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA; [email protected] (T.A.); [email protected] (M.-L.H.) * Correspondence: [email protected]; Tel.: +1-904-953-2483 Received: 28 December 2017; Accepted: 3 February 2018; Published: 5 February 2018 Abstract: The ATP-binding cassette (ABC) reporter family functions to regulate the homeostasis of phospholipids and cholesterol in the central nervous system, as well as peripheral tissues. ABCA7 belongs to the A subfamily of ABC transporters, which shares 54% sequence identity with ABCA1. While ABCA7 is expressed in a variety of tissues/organs, including the brain, recent genome-wide association studies (GWAS) have identified ABCA7 gene variants as susceptibility loci for late-onset Alzheimer’s disease (AD). More important, subsequent genome sequencing analyses have revealed that premature termination codon mutations in ABCA7 are associated with the increased risk for AD. Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia, where the accumulation and deposition of amyloid-β (Aβ) peptides cleaved from amyloid precursor protein (APP) in the brain trigger the pathogenic cascade of the disease. In consistence with human genetic studies, increasing evidence has demonstrated that ABCA7 deficiency exacerbates Aβ pathology using in vitro and in vivo models. While ABCA7 has been shown to mediate phagocytic activity in macrophages, ABCA7 is also involved in the microglial Aβ clearance pathway. Furthermore, ABCA7 deficiency results in accelerated Aβ production, likely by facilitating endocytosis and/or processing of APP. -
Whole Exome Sequencing Analysis of ABCC8 and ABCD2 Genes Associating with Clinical Course of Breast Carcinoma
Physiol. Res. 64 (Suppl. 4): S549-S557, 2015 Whole Exome Sequencing Analysis of ABCC8 and ABCD2 Genes Associating With Clinical Course of Breast Carcinoma P. SOUCEK1,2, V. HLAVAC1,2,3, K. ELSNEROVA1,2,3, R. VACLAVIKOVA2, R. KOZEVNIKOVOVA4, K. RAUS5 1Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic, 2Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic, 3Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, 4Department of Oncosurgery, Medicon, Prague, Czech Republic, 5Institute for the Care for Mother and Child, Prague, Czech Republic Received September 17, 2015 Accepted October 2, 2015 Summary Charles University in Prague, Alej Svobody 76, 323 00 Pilsen, The aim of the present study was to introduce methods for Czech Republic. E-mail: [email protected] exome sequencing of two ATP-binding cassette (ABC) transporters ABCC8 and ABCD2 recently suggested to play Introduction a putative role in breast cancer progression and prognosis of patients. We performed next generation sequencing targeted at Breast cancer is the most common cancer in analysis of all exons in ABCC8 and ABCD2 genes and surrounding women and caused 471,000 deaths worldwide in 2013 noncoding sequences in blood DNA samples from 24 patients (Global Burden of Disease Cancer Collaboration 2015). with breast cancer. The revealed alterations were characterized A number of cellular processes that in some cases lead to the by in silico tools. We then compared the most frequent tumor resistance limits efficacy of breast cancer therapy. functionally relevant polymorphism rs757110 in ABCC8 with Multidrug resistance (MDR) to a variety of chemotherapy clinical data of patients.